Kringle Pharma is a clinical-stage biopharmaceutical company that focuses on the research and development of regenerative medicines. It offers protein drug substance products for the treatment of vocal cord scarring, acute kidney and spinal cord injury, amyotrophic lateral sclerosis, cancer patients, etc.